Lyra Therapeutics Inc
(NASDAQ:LYRA)
$2.7697
0.1097[4.12%]
Last update: 10:39AM (Delayed 15-Minutes)
Get Real Time Here
Day Range2.680 - 2.80052 Wk Range2.350 - 8.180Open / Close2.780 / -Float / Outstanding18.241M / 31.827M
Vol / Avg.15.924K / 66.137KMkt Cap88.151MP/E-50d Avg. Price3.090
Div / Yield (Forward)- / -%Payout Ratio-Total Float18.241MEPS-2.520

Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary

Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.

Loading...
Day Range2.680 - 2.80052 Wk Range2.350 - 8.180Open / Close2.780 / -Float / Outstanding18.241M / 31.827M
Vol / Avg.15.924K / 66.137KMkt Cap88.151MP/E-50d Avg. Price3.090
Div / Yield (Forward)- / -%Payout Ratio-Total Float18.241MEPS-2.520
Seeking Alpha - May 18, 2022, 12:46PM
InvestorPlace - Apr 27, 2022, 6:31AM
TipRanks - Apr 25, 2022, 10:43PM
Seeking Alpha - Apr 21, 2022, 10:53AM
TipRanks - Apr 20, 2022, 7:21AM
InvestorsObserver - Apr 12, 2022, 7:17AM
Sector: Health Care.Industry: Pharmaceuticals
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-08
REV
Q3 2022Est.ActualSurprise
EPS-0.440-0.400 0.0400
REV140.000K359.000K219.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Lyra Therapeutics (LYRA) stock?

A

You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lyra Therapeutics's (LYRA) competitors?

Q

What is the target price for Lyra Therapeutics (LYRA) stock?

A

The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lyra Therapeutics (LYRA)?

A

The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.

Q

Does Lyra Therapeutics (LYRA) pay a dividend?

A

There are no upcoming dividends for Lyra Therapeutics.

Q

When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?

A

Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.

Q

Is Lyra Therapeutics (LYRA) going to split?

A

There is no upcoming split for Lyra Therapeutics.

Q

What sector and industry does Lyra Therapeutics (LYRA) operate in?

A

Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary

Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.

Loading...
Day Range2.680 - 2.80052 Wk Range2.350 - 8.180Open / Close2.780 / -Float / Outstanding18.241M / 31.827M
Vol / Avg.15.924K / 66.137KMkt Cap88.151MP/E-50d Avg. Price3.090
Div / Yield (Forward)- / -%Payout Ratio-Total Float18.241MEPS-2.520
Seeking Alpha - May 18, 2022, 12:46PM
InvestorPlace - Apr 27, 2022, 6:31AM
TipRanks - Apr 25, 2022, 10:43PM
Seeking Alpha - Apr 21, 2022, 10:53AM
TipRanks - Apr 20, 2022, 7:21AM
InvestorsObserver - Apr 12, 2022, 7:17AM
Sector: Health Care.Industry: Pharmaceuticals
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-08
REV
Q3 2022Est.ActualSurprise
EPS-0.440-0.400 0.0400
REV140.000K359.000K219.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Lyra Therapeutics (LYRA) stock?

A

You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lyra Therapeutics's (LYRA) competitors?

Q

What is the target price for Lyra Therapeutics (LYRA) stock?

A

The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lyra Therapeutics (LYRA)?

A

The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.

Q

Does Lyra Therapeutics (LYRA) pay a dividend?

A

There are no upcoming dividends for Lyra Therapeutics.

Q

When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?

A

Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.

Q

Is Lyra Therapeutics (LYRA) going to split?

A

There is no upcoming split for Lyra Therapeutics.

Q

What sector and industry does Lyra Therapeutics (LYRA) operate in?

A

Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary

Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.

Loading...
Day Range2.680 - 2.80052 Wk Range2.350 - 8.180Open / Close2.780 / -Float / Outstanding18.241M / 31.827M
Vol / Avg.15.924K / 66.137KMkt Cap88.151MP/E-50d Avg. Price3.090
Div / Yield (Forward)- / -%Payout Ratio-Total Float18.241MEPS-2.520
Seeking Alpha - May 18, 2022, 12:46PM
InvestorPlace - Apr 27, 2022, 6:31AM
TipRanks - Apr 25, 2022, 10:43PM
Seeking Alpha - Apr 21, 2022, 10:53AM
TipRanks - Apr 20, 2022, 7:21AM
InvestorsObserver - Apr 12, 2022, 7:17AM
Sector: Health Care.Industry: Pharmaceuticals
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-08
REV
Q3 2022Est.ActualSurprise
EPS-0.440-0.400 0.0400
REV140.000K359.000K219.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Lyra Therapeutics (LYRA) stock?

A

You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lyra Therapeutics's (LYRA) competitors?

Q

What is the target price for Lyra Therapeutics (LYRA) stock?

A

The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lyra Therapeutics (LYRA)?

A

The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.

Q

Does Lyra Therapeutics (LYRA) pay a dividend?

A

There are no upcoming dividends for Lyra Therapeutics.

Q

When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?

A

Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.

Q

Is Lyra Therapeutics (LYRA) going to split?

A

There is no upcoming split for Lyra Therapeutics.

Q

What sector and industry does Lyra Therapeutics (LYRA) operate in?

A

Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary

Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.

Loading...
Day Range2.680 - 2.80052 Wk Range2.350 - 8.180Open / Close2.780 / -Float / Outstanding18.241M / 31.827M
Vol / Avg.15.924K / 66.137KMkt Cap88.151MP/E-50d Avg. Price3.090
Div / Yield (Forward)- / -%Payout Ratio-Total Float18.241MEPS-2.520
Seeking Alpha - May 18, 2022, 12:46PM
InvestorPlace - Apr 27, 2022, 6:31AM
TipRanks - Apr 25, 2022, 10:43PM
Seeking Alpha - Apr 21, 2022, 10:53AM
TipRanks - Apr 20, 2022, 7:21AM
InvestorsObserver - Apr 12, 2022, 7:17AM
Sector: Health Care.Industry: Pharmaceuticals
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-08
REV
Q3 2022Est.ActualSurprise
EPS-0.440-0.400 0.0400
REV140.000K359.000K219.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Lyra Therapeutics (LYRA) stock?

A

You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lyra Therapeutics's (LYRA) competitors?

Q

What is the target price for Lyra Therapeutics (LYRA) stock?

A

The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lyra Therapeutics (LYRA)?

A

The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.

Q

Does Lyra Therapeutics (LYRA) pay a dividend?

A

There are no upcoming dividends for Lyra Therapeutics.

Q

When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?

A

Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.

Q

Is Lyra Therapeutics (LYRA) going to split?

A

There is no upcoming split for Lyra Therapeutics.

Q

What sector and industry does Lyra Therapeutics (LYRA) operate in?

A

Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary

Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.

Loading...
Day Range2.680 - 2.80052 Wk Range2.350 - 8.180Open / Close2.780 / -Float / Outstanding18.241M / 31.827M
Vol / Avg.15.924K / 66.137KMkt Cap88.151MP/E-50d Avg. Price3.090
Div / Yield (Forward)- / -%Payout Ratio-Total Float18.241MEPS-2.520
Seeking Alpha - May 18, 2022, 12:46PM
InvestorPlace - Apr 27, 2022, 6:31AM
TipRanks - Apr 25, 2022, 10:43PM
Seeking Alpha - Apr 21, 2022, 10:53AM
TipRanks - Apr 20, 2022, 7:21AM
InvestorsObserver - Apr 12, 2022, 7:17AM
Sector: Health Care.Industry: Pharmaceuticals
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-08
REV
Q3 2022Est.ActualSurprise
EPS-0.440-0.400 0.0400
REV140.000K359.000K219.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Lyra Therapeutics (LYRA) stock?

A

You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lyra Therapeutics's (LYRA) competitors?

Q

What is the target price for Lyra Therapeutics (LYRA) stock?

A

The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lyra Therapeutics (LYRA)?

A

The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.

Q

Does Lyra Therapeutics (LYRA) pay a dividend?

A

There are no upcoming dividends for Lyra Therapeutics.

Q

When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?

A

Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.

Q

Is Lyra Therapeutics (LYRA) going to split?

A

There is no upcoming split for Lyra Therapeutics.

Q

What sector and industry does Lyra Therapeutics (LYRA) operate in?

A

Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary

Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.

Loading...
Day Range2.680 - 2.80052 Wk Range2.350 - 8.180Open / Close2.780 / -Float / Outstanding18.241M / 31.827M
Vol / Avg.15.924K / 66.137KMkt Cap88.151MP/E-50d Avg. Price3.090
Div / Yield (Forward)- / -%Payout Ratio-Total Float18.241MEPS-2.520
Seeking Alpha - May 18, 2022, 12:46PM
InvestorPlace - Apr 27, 2022, 6:31AM
TipRanks - Apr 25, 2022, 10:43PM
Seeking Alpha - Apr 21, 2022, 10:53AM
TipRanks - Apr 20, 2022, 7:21AM
InvestorsObserver - Apr 12, 2022, 7:17AM
Sector: Health Care.Industry: Pharmaceuticals
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-08
REV
Q3 2022Est.ActualSurprise
EPS-0.440-0.400 0.0400
REV140.000K359.000K219.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Lyra Therapeutics (LYRA) stock?

A

You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lyra Therapeutics's (LYRA) competitors?

Q

What is the target price for Lyra Therapeutics (LYRA) stock?

A

The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lyra Therapeutics (LYRA)?

A

The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.

Q

Does Lyra Therapeutics (LYRA) pay a dividend?

A

There are no upcoming dividends for Lyra Therapeutics.

Q

When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?

A

Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.

Q

Is Lyra Therapeutics (LYRA) going to split?

A

There is no upcoming split for Lyra Therapeutics.

Q

What sector and industry does Lyra Therapeutics (LYRA) operate in?

A

Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary

Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.

Loading...
Day Range2.680 - 2.80052 Wk Range2.350 - 8.180Open / Close2.780 / -Float / Outstanding18.241M / 31.827M
Vol / Avg.15.924K / 66.137KMkt Cap88.151MP/E-50d Avg. Price3.090
Div / Yield (Forward)- / -%Payout Ratio-Total Float18.241MEPS-2.520
Seeking Alpha - May 18, 2022, 12:46PM
InvestorPlace - Apr 27, 2022, 6:31AM
TipRanks - Apr 25, 2022, 10:43PM
Seeking Alpha - Apr 21, 2022, 10:53AM
TipRanks - Apr 20, 2022, 7:21AM
InvestorsObserver - Apr 12, 2022, 7:17AM
Sector: Health Care.Industry: Pharmaceuticals
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-08
REV
Q3 2022Est.ActualSurprise
EPS-0.440-0.400 0.0400
REV140.000K359.000K219.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Lyra Therapeutics (LYRA) stock?

A

You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lyra Therapeutics's (LYRA) competitors?

Q

What is the target price for Lyra Therapeutics (LYRA) stock?

A

The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lyra Therapeutics (LYRA)?

A

The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.

Q

Does Lyra Therapeutics (LYRA) pay a dividend?

A

There are no upcoming dividends for Lyra Therapeutics.

Q

When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?

A

Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.

Q

Is Lyra Therapeutics (LYRA) going to split?

A

There is no upcoming split for Lyra Therapeutics.

Q

What sector and industry does Lyra Therapeutics (LYRA) operate in?

A

Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary

Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.

Loading...
Day Range2.680 - 2.80052 Wk Range2.350 - 8.180Open / Close2.780 / -Float / Outstanding18.241M / 31.827M
Vol / Avg.15.924K / 66.137KMkt Cap88.151MP/E-50d Avg. Price3.090
Div / Yield (Forward)- / -%Payout Ratio-Total Float18.241MEPS-2.520
Seeking Alpha - May 18, 2022, 12:46PM
InvestorPlace - Apr 27, 2022, 6:31AM
TipRanks - Apr 25, 2022, 10:43PM
Seeking Alpha - Apr 21, 2022, 10:53AM
TipRanks - Apr 20, 2022, 7:21AM
InvestorsObserver - Apr 12, 2022, 7:17AM
Sector: Health Care.Industry: Pharmaceuticals
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-08
REV
Q3 2022Est.ActualSurprise
EPS-0.440-0.400 0.0400
REV140.000K359.000K219.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Lyra Therapeutics (LYRA) stock?

A

You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lyra Therapeutics's (LYRA) competitors?

Q

What is the target price for Lyra Therapeutics (LYRA) stock?

A

The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lyra Therapeutics (LYRA)?

A

The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.

Q

Does Lyra Therapeutics (LYRA) pay a dividend?

A

There are no upcoming dividends for Lyra Therapeutics.

Q

When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?

A

Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.

Q

Is Lyra Therapeutics (LYRA) going to split?

A

There is no upcoming split for Lyra Therapeutics.

Q

What sector and industry does Lyra Therapeutics (LYRA) operate in?

A

Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary

Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.

Loading...
Day Range2.680 - 2.80052 Wk Range2.350 - 8.180Open / Close2.780 / -Float / Outstanding18.241M / 31.827M
Vol / Avg.15.924K / 66.137KMkt Cap88.151MP/E-50d Avg. Price3.090
Div / Yield (Forward)- / -%Payout Ratio-Total Float18.241MEPS-2.520
Seeking Alpha - May 18, 2022, 12:46PM
InvestorPlace - Apr 27, 2022, 6:31AM
TipRanks - Apr 25, 2022, 10:43PM
Seeking Alpha - Apr 21, 2022, 10:53AM
TipRanks - Apr 20, 2022, 7:21AM
InvestorsObserver - Apr 12, 2022, 7:17AM
Sector: Health Care.Industry: Pharmaceuticals
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-08
REV
Q3 2022Est.ActualSurprise
EPS-0.440-0.400 0.0400
REV140.000K359.000K219.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Lyra Therapeutics (LYRA) stock?

A

You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lyra Therapeutics's (LYRA) competitors?

Q

What is the target price for Lyra Therapeutics (LYRA) stock?

A

The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lyra Therapeutics (LYRA)?

A

The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.

Q

Does Lyra Therapeutics (LYRA) pay a dividend?

A

There are no upcoming dividends for Lyra Therapeutics.

Q

When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?

A

Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.

Q

Is Lyra Therapeutics (LYRA) going to split?

A

There is no upcoming split for Lyra Therapeutics.

Q

What sector and industry does Lyra Therapeutics (LYRA) operate in?

A

Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.